Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
Published online before print September 3, 2008, doi:10.1212/01.wnl.0000327339.55844.1a)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Podcast
Right arrow All Versions of this Article:
01.wnl.0000327339.55844.1av1
72/8/688    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaturvedi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaturvedi, S.
Related Collections
Right arrow Stroke prevention
Right arrow Infarction
Right arrowRelated Article
NEUROLOGY 2009;72:688-694
© 2009 American Academy of Neurology

Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack

S. Chaturvedi, MD, J. Zivin, MD, PhD, A. Breazna, PhD, P. Amarenco, MD, A. Callahan, MD, L. B. Goldstein, MD, M. Hennerici, MD, H. Sillesen, MD, A. Rudolph, PhD, M. A. Welch, MD, PhD For the SPARCL Investigators*

From Wayne State University (S.C.), Detroit, MI; University of California (J.Z.), San Diego; Pfizer (A.B., A.R.), New York, NY; Denis Diderot University (P.A.), Paris, France; Neurologic Consultants (A.C.), Nashville, TN; Duke University Medical Center (L.B.G.), Durham, NC; University of Heidelberg (M.H.), Mannheim, Germany; University of Copenhagen (H.S.), Denmark; and Rosalind Franklin University of Medicine and Science (M.A.W.), North Chicago, IL.

Address correspondence and reprint requests to Dr. Seemant Chaturvedi, Stroke Program and Department of Neurology, Wayne State University, 8C-UHC, 4201 St. Antoine, Detroit, MI 48201 SChaturv{at}med.wayne.edu

Background: It is unclear whether patients age 65 years and over with a recent stroke or TIA benefit from statin treatment to a similar degree as younger patients.

Methods: The 4,731 patient cohort in the SPARCL study was divided into an elderly group (65 and over) and a younger group. The primary endpoint (fatal or nonfatal stroke) and secondary endpoints were analyzed, with calculation of the hazard ratio (HR) and p values from a Cox regression model.

Results: There were 2,249 patients in the elderly group and 2,482 in the younger group. The baseline LDL (133 mg/dL) and total cholesterol were comparable in the two groups. The elderly and younger groups had a 61.4 mg/dL and 58.7 mg/dL decrease in mean LDL during the trial. The primary endpoint was reduced by 26% in younger patients (HR 0.74, 0.57–0.96, p = 0.02) and by 10% in elderly subjects (HR 0.90, 0.73–1.11, p = 0.33). A test of heterogeneity for a treatment–age interaction was not significant (p = 0.52). The risk of stroke or TIA (HR 0.79, p = 0.01), major coronary events (HR 0.68, p = 0.035), any coronary heart disease event (HR 0.61, p = 0.0006), and revascularization procedures (HR 0.55, p = 0.0005) was reduced in the elderly group.

Conclusions: There was no heterogeneity in the stroke reduction seen with atorvastatin in the elderly and younger groups. Cardiac events and revascularization procedures were also lower in both the elderly and younger subgroups treated with atorvastatin. These results support the use of atorvastatin in elderly patients with recent stroke or TIA.

CHD = coronary heart disease; LDL-C = low-density lipoprotein cholesterol; RRR = relative risk reduction; SPARCL = Stroke Prevention by Aggressive Reduction in Cholesterol Levels.


Editorial, page 684

e-Pub ahead of print on September 3, 2008, at www.neurology.org.

*The SPARCL Investigators are listed in the appendix.

Disclosure: Author disclosures are provided at the end of the article.

Received November 6, 2007. Accepted in final form May 2, 2008.


Related Article

Statins: Not just for the young or the faint of heart
Bruce M. Coull and S. Claiborne Johnston
Neurology 2009 72: 684-685. [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
A. A. Rabinstein
Statins Prevent Stroke Recurrences... But Can They Improve Stroke Outcome?
Stroke, November 1, 2009; 40(11): 3413 - 3414.
[Full Text] [PDF]


Home page
NeurologyHome page
W. Landau, M. Strupp, M. T. Bianchi, B. Westover, and S. Chaturvedi FAHA, FAAN
EFFECT OF ATORVASTATIN IN ELDERLY PATIENTS WITH A RECENT STROKE OR TRANSIENT ISCHEMIC ATTACK
Neurology, September 8, 2009; 73(10): 817 - 819.
[Full Text] [PDF]


Home page
NeurologyHome page
L. Castilla-Guerra, M. del Carmen Fernandez-Moreno, M. D. Jimenez-Hernandez, and S. Chaturvedi
EFFECT OF ATORVASTATIN IN ELDERLY PATIENTS WITH A RECENT STROKE OR TRANSIENT ISCHEMIC ATTACK
Neurology, July 21, 2009; 73(3): 248 - 249.
[Full Text] [PDF]


Home page
NeurologyHome page
H. J. Milionis, S. Giannopoulos, M. Kosmidou, V. Panoulas, E. Manios, A. P. Kyritsis, M. S. Elisaf, and K. Vemmos
Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival
Neurology, May 26, 2009; 72(21): 1816 - 1822.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. R. Goldstein, L. Mascitelli, F. Pezzetta, and L. B. Goldstein
HEMORRHAGIC STROKE IN THE STROKE PREVENTION BY AGGRESSIVE REDUCTION IN CHOLESTEROL LEVELS STUDY
Neurology, April 21, 2009; 72(16): 1448 - 1449.
[Full Text] [PDF]


Home page
NeurologyHome page
B. M. Coull and S. C. Johnston
Statins: Not just for the young or the faint of heart
Neurology, February 24, 2009; 72(8): 684 - 685.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
Luca Mascitelli, et al.
Neurology Online, 21 Nov 2008 [Full text]
Reply from the author
Seemant Chaturvedi
Neurology Online, 21 Nov 2008 [Full text]
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
Luis Castilla-Guerra, et al.
Neurology Online, 15 Jan 2009 [Full text]
Reply from the author
Seemant Chaturvedi
Neurology Online, 15 Jan 2009 [Full text]
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
Michael Strupp
Neurology Online, 22 Jun 2009 [Full text]
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
William Landau
Neurology Online, 22 Jun 2009 [Full text]
Reply from the author
Seemant Chaturvedi MD, FAHA, FAAN
Neurology Online, 22 Jun 2009 [Full text]
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
Matt T. Bianchi MD PhD, et al.
Neurology Online, 22 Jun 2009 [Full text]